|
AU4077701A
|
|
Agent for use in method of treatment
|
|
GB9927757D0
|
|
Treatment of autoimmune diseases
|
|
GB9922505D0
|
|
Therapeutic methods and compounds
|
|
GB9922283D0
|
|
Adenoviral vectors
|
|
GB9922281D0
|
|
Polymorphism
|
|
US7070783B1
|
|
Small molecular weight TNF receptor multimeric molecule
|
|
GB9906396D0
|
|
Use of galectin-1 to treat inflammatory and autoimmune diseases
|
|
GB9822434D0
|
|
Mesenchymal precursor cells
|
|
EP1012321A2
|
|
Viral infection of cells using viral vectors
|
|
GB9814892D0
|
|
Treatment of celiac disease
|
|
GB9807639D0
|
|
Anti-inflammatory agents
|
